259 related articles for article (PubMed ID: 23172153)
1. Screening therapeutic EMT blocking agents in a three-dimensional microenvironment.
Aref AR; Huang RY; Yu W; Chua KN; Sun W; Tu TY; Bai J; Sim WJ; Zervantonakis IK; Thiery JP; Kamm RD
Integr Biol (Camb); 2013 Feb; 5(2):381-9. PubMed ID: 23172153
[TBL] [Abstract][Full Text] [Related]
2. Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment.
Bai J; Tu TY; Kim C; Thiery JP; Kamm RD
Oncotarget; 2015 Nov; 6(34):36603-14. PubMed ID: 26474384
[TBL] [Abstract][Full Text] [Related]
3. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
4. A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screening.
Kuo CT; Liu HK; Huang GS; Chang CH; Chen CL; Chen KC; Huang RY; Lin CH; Lee H; Huang CS; Wo AM
Analyst; 2014 Oct; 139(19):4846-54. PubMed ID: 25089836
[TBL] [Abstract][Full Text] [Related]
5. LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
Yang D; Cao X; Wang F; Jiang H; Feng D; Guo H; Du L; Jin Y; Chen Y; Yin X; Li C
Cancer Lett; 2017 Aug; 400():137-148. PubMed ID: 28461245
[TBL] [Abstract][Full Text] [Related]
6. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
[TBL] [Abstract][Full Text] [Related]
7. Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions.
Bai J; Adriani G; Dang TM; Tu TY; Penny HX; Wong SC; Kamm RD; Thiery JP
Oncotarget; 2015 Sep; 6(28):25295-307. PubMed ID: 26231039
[TBL] [Abstract][Full Text] [Related]
8. Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.
Singh M; Close DA; Mukundan S; Johnston PA; Sant S
Assay Drug Dev Technol; 2015 Nov; 13(9):570-83. PubMed ID: 26274587
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.
Lee JH; Kim SK; Khawar IA; Jeong SY; Chung S; Kuh HJ
J Exp Clin Cancer Res; 2018 Jan; 37(1):4. PubMed ID: 29329547
[TBL] [Abstract][Full Text] [Related]
10. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
11. Comparison of EMT-Related and Multi-Drug Resistant Gene Expression, Extracellular Matrix Production, and Drug Sensitivity in NSCLC Spheroids Generated by Scaffold-Free and Scaffold-Based Methods.
Qi X; Prokhorova AV; Mezentsev AV; Shen N; Trofimenko AV; Filkov GI; Sulimanov RA; Makarov VA; Durymanov MO
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362093
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma.
Lou Y; Diao L; Cuentas ER; Denning WL; Chen L; Fan YH; Byers LA; Wang J; Papadimitrakopoulou VA; Behrens C; Rodriguez JC; Hwu P; Wistuba II; Heymach JV; Gibbons DL
Clin Cancer Res; 2016 Jul; 22(14):3630-42. PubMed ID: 26851185
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-hyaluronan based 3D co-culture platform for studying the crosstalk of lung cancer cells and mesenchymal stem cells.
Han HW; Hsu SH
Acta Biomater; 2016 Sep; 42():157-167. PubMed ID: 27296841
[TBL] [Abstract][Full Text] [Related]
14. A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds.
Göttlich C; Müller LC; Kunz M; Schmitt F; Walles H; Walles T; Dandekar T; Dandekar G; Nietzer SL
J Vis Exp; 2016 Apr; (110):e53885. PubMed ID: 27077967
[TBL] [Abstract][Full Text] [Related]
15. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
[TBL] [Abstract][Full Text] [Related]
16. Metastatic behavior analyses of tetraspanin TM4SF5-expressing spheres in three-dimensional (3D) cell culture environment.
Song DG; Kim E; Lee JW
Arch Pharm Res; 2020 Nov; 43(11):1162-1172. PubMed ID: 33222072
[TBL] [Abstract][Full Text] [Related]
17. Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening.
Xu X; Tang L
Curr Pharm Des; 2017; 23(11):1710-1720. PubMed ID: 27908265
[TBL] [Abstract][Full Text] [Related]
18. Multicomponent Coculture System of Cancer Cells and Two Types of Stromal Cells for In Vitro Evaluation of Anticancer Drugs.
Yamazoe H; Hagihara Y; Kobayashi H
Tissue Eng Part C Methods; 2016 Jan; 22(1):20-9. PubMed ID: 26421875
[TBL] [Abstract][Full Text] [Related]
19. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
[TBL] [Abstract][Full Text] [Related]
20. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
